TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33370867

Group type: EXPERIMENTAL
Intervention: Kangbingdu granules (KBD), 18g each time, 3 times a day for 5 days
Number of subjects: 393

Group type: COMPARATOR
Intervention: Oseltamivir phosphate capsule, 75 mg each time, twice a day for 5 days
Number of subjects: 393
Study: 32382987

Group type: EXPERIMENTAL
Intervention: Real-world evidence (RWE) studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequencing of novel agents based on RWE data
Number of subjects: 0
Study: 35077456

Group type: EXPERIMENTAL
Intervention: Topiroxostat
Number of subjects: 141

Group type: COMPARATOR
Intervention: Allopurinol
Number of subjects: 141
Study: 33412120

Group type: EXPERIMENTAL
Intervention: Nintedanib (150 mg orally twice daily)
Number of subjects: 576

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 576

Group type: COMPARATOR
Intervention: Nintedanib and Placebo
Number of subjects: 576
Study: 35678081

Group type: EXPERIMENTAL
Intervention: Critical time intervention‐task shifting (CTI‐TS) for 9 months
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual care for 9 months
Number of subjects: 110
Study: 34091874

Group type: EXPERIMENTAL
Intervention: Citicoline and vitamin B12 eye drops (OMK2®, Omikron Italia srl, Italy, one drop thrice daily) for 36 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (eye drops containing hypromellose 0.3%, one drop thrice daily) for 36 months
Number of subjects: 20
Study: 32787893

Group type: EXPERIMENTAL
Intervention: Thursdays at the Museum (art-based workshops)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no participation in art-based activities)
Number of subjects: 150
Study: 34142455

Group type: EXPERIMENTAL
Intervention: 3D anatomy application
Number of subjects: 76

Group type: COMPARATOR
Intervention: Anatomy atlases
Number of subjects: 76
Study: 34960030

Group type: EXPERIMENTAL
Intervention: 50 mg PXN + 150 mg PLA
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100 mg PXN + 100 mg PLA
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 200 mg PXN
Number of subjects: 12

Group type: COMPARATOR
Intervention: 200 mg PLA
Number of subjects: 12
Study: 35115348

Group type: EXPERIMENTAL
Intervention: Self-sampling HPV test
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Routine cervical cancer screening (cytology test)
Number of subjects: 20000
Study: 33910657

Group type: EXPERIMENTAL
Intervention: Resident involvement
Number of subjects: 11733

Group type: COMPARATOR
Intervention: Control (no resident involvement)
Number of subjects: 11733
Study: 36309929

Group type: EXPERIMENTAL
Intervention: Unified Transdiagnostic Protocol (UP) for 10 sessions
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction Protocol (MBSR) for 8 sessions
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 45
Study: 34037889

Group type: EXPERIMENTAL
Intervention: ECP (300 mmHg)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham/control (75 mmHg)
Number of subjects: 43
Study: 32896158

Group type: EXPERIMENTAL
Intervention: Positive CMC
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Negative CMC
Number of subjects: 62

Group type: COMPARATOR
Intervention: Blog
Number of subjects: 62
Study: 32098895

Group type: EXPERIMENTAL
Intervention: Polyclonal Tregs
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Proinsulin-specific Tregs
Number of subjects: 3

Group type: COMPARATOR
Intervention: Long-duration T1DM (LDT1DM)
Number of subjects: 3
Study: 35459194

Group type: EXPERIMENTAL
Intervention: CBEP-HCP (community-based exercise program with healthcare-community partnerships)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 33
Study: 32665211

Group type: EXPERIMENTAL
Intervention: Hiraoka's TUDP
Number of subjects: 104

Group type: COMPARATOR
Intervention: TURP
Number of subjects: 104
Study: 33306939

Group type: EXPERIMENTAL
Intervention: LPG stove intervention with continuous fuel delivery for 1 year, education, and behavioral messaging
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group continued usual cooking practices
Number of subjects: 180
Study: 36104785

Group type: EXPERIMENTAL
Intervention: Nebulised unfractionated heparin 6 hourly to day 10 while receiving advanced respiratory support
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 40
Study: 34101937

Group type: EXPERIMENTAL
Intervention: Brief mindfulness instructions
Number of subjects: 62

Group type: COMPARATOR
Intervention: Suppression instructions
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Unconditioned (novel-cued) stimuli
Number of subjects: 62
Study: 32854153

Group type: EXPERIMENTAL
Intervention: Work-HIIT (n = 24)
Number of subjects: 47
Study: 36206973

Group type: EXPERIMENTAL
Intervention: Thoracic configuration assessment
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Correlation analysis between thoracic area and spirometry variables
Number of subjects: 90
Study: 33403886

Group type: EXPERIMENTAL
Intervention: Blood Pressure <140/90 mmHg
Number of subjects: 5250

Group type: EXPERIMENTAL
Intervention: Blood Pressure <130/80 mmHg
Number of subjects: 5250
Study: 32727416

Group type: EXPERIMENTAL
Intervention: Transoral surgical resection with neck dissection followed by risk-adapted adjuvant therapy
Number of subjects: 280

Group type: COMPARATOR
Intervention: Standard chemoradiation
Number of subjects: 280
Study: 36497969

Group type: EXPERIMENTAL
Intervention: Training intervention in energy management strategies
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 86
Study: 33811385

Group type: EXPERIMENTAL
Intervention: Linked color imaging (LCI)
Number of subjects: 90

Group type: COMPARATOR
Intervention: White light imaging (WLI)
Number of subjects: 90
Study: 35675742

Group type: EXPERIMENTAL
Intervention: Bee-humming respiratory training (BHRT), 30 minutes daily for 4 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Bee-humming respiratory training (BHRT)
Number of subjects: 46
Study: 33650100

Group type: EXPERIMENTAL
Intervention: Carfilzomib (20 mg/m2 on day 1, escalating to 56 mg/m2 maximum) with dexamethasone (10 mg as premedication) during maintenance
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Carfilzomib with cyclophosphamide and dexamethasone (KCd) during induction
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Carfilzomib during KCd consolidation
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Maintenance single-agent carfilzomib
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Overall TMA incidence
Number of subjects: 8
Study: 33471664

Group type: EXPERIMENTAL
Intervention: Multidisciplinary diabetes program
Number of subjects: 192

Group type: COMPARATOR
Intervention: Standard primary care setting (control group)
Number of subjects: 192
Study: 34964860

Group type: EXPERIMENTAL
Intervention: MARPE
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: RPE
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 32960350

Group type: EXPERIMENTAL
Intervention: Smartphone otoscope
Number of subjects: 52

Group type: COMPARATOR
Intervention: Traditional otoscope
Number of subjects: 52
Study: 35685082

Group type: EXPERIMENTAL
Intervention: GA + ESPB
Number of subjects: 60

Group type: COMPARATOR
Intervention: GA
Number of subjects: 60
Study: 34369682

Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with ultrasound guided caudal epidural injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ultrasound guided caudal epidural injection
Number of subjects: 60
Study: 36414626

Group type: EXPERIMENTAL
Intervention: KarXT (xanomeline-trospium)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 33955318

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 105
Study: 36087136

Group type: EXPERIMENTAL
Intervention: Nutritional counselling intervention based on unprocessed and minimally processed foods and physical activities
Number of subjects: 350

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 350
Study: 33401605

Group type: EXPERIMENTAL
Intervention: HIIT intervention and health education
Number of subjects: 70

Group type: COMPARATOR
Intervention: Health education alone
Number of subjects: 70
Study: 32805626

Group type: EXPERIMENTAL
Intervention: Genetically-predicted TNF levels
Number of subjects: 30912
Study: 34384513

Group type: EXPERIMENTAL
Intervention: Water Schools intervention (providing free refillable water bottles and educational material)
Number of subjects: 569

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 569
Study: 33566077

Group type: EXPERIMENTAL
Intervention: Fluorides for intensive prophylaxis for the first month
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Chlorhexidine for intensive prophylaxis for the first month
Number of subjects: 36

Group type: COMPARATOR
Intervention: Regular oral hygiene (Control group)
Number of subjects: 36
Study: 35932953

Group type: EXPERIMENTAL
Intervention: Furmonertinib 80mg Qd
Number of subjects: 358

Group type: COMPARATOR
Intervention: Gefitinib 250mg Qd
Number of subjects: 358
Study: 33434565

Group type: EXPERIMENTAL
Intervention: Fully automated AI-driven tooth segmentation (F-AI)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Refined AI-driven tooth segmentation (R-AI)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Semiautomated tooth segmentation (SA)
Number of subjects: 314
Study: 35634694

Group type: EXPERIMENTAL
Intervention: Lemborexant 10 mg plus alcohol (males, 0.7 g/kg; females, 0.6 g/kg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Alcohol alone
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Lemborexant 10 mg alone
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Lemborexant 10 mg plus alcohol
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Lemborexant 10 mg alone or with alcohol
Number of subjects: 32
Study: 35754259

Group type: EXPERIMENTAL
Intervention: Combined pain competence and depression prevention training (n=271)
Number of subjects: 526

Group type: COMPARATOR
Intervention: Pain competence training (control group, n=255)
Number of subjects: 526
Study: 33185932

Group type: EXPERIMENTAL
Intervention: Low-dose isotretinoin (0.25 mg/kg/day) and five sessions of pulsed dye laser (PDL)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard-dose isotretinoin (0.5 mg/kg/day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: ISO group (0.5 mg/kg/day)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: ISO/PDL group (0.25 mg/kg/day + PDL)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: ISO/PDL group
Number of subjects: 46
Study: 35721734

Group type: EXPERIMENTAL
Intervention: Adrenalectomy (Arm A)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conservative approach (Arm B)
Number of subjects: 62
Study: 34256668

Group type: EXPERIMENTAL
Intervention: Cilta-cel (ciltacabtagene autoleucel)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ide-cel (idecabtagene vicleucel)
Number of subjects: 0
Study: 35879941

Group type: EXPERIMENTAL
Intervention: 10 µg GBP510 adjuvanted with AS03 (Group 1)
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: 10 µg unadjuvanted GBP510 (Group 2)
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: 25 µg GBP510 adjuvanted with AS03 (Group 3)
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: 25 µg unadjuvanted GBP510 (Group 4)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: 10 µg or 25 µg GBP510 adjuvanted with AS03
Number of subjects: 328
Study: 33752636

Group type: EXPERIMENTAL
Intervention: Clinical, immunological and VL monitoring
Number of subjects: 142

Group type: COMPARATOR
Intervention: Clinical and immunological monitoring (control)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Longer duration of ART exposure
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Virologic failure
Number of subjects: 142
Study: 32195934

Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg at bedtime
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 616671307

Group type: EXPERIMENTAL
Intervention: Modified MSLT performed at home
Number of subjects: 34

Group type: COMPARATOR
Intervention: Modified MSLT performed in the hospital
Number of subjects: 34
Study: 36127677

Group type: COMPARATOR
Intervention: exercise (physiotherapist‐prescribed exercise)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: exercise plus app (physiotherapist‐prescribed exercise plus access to the ‘My Exercise Messages’ mobile app)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: exercise plus app
Number of subjects: 182
Study: 34001223

Group type: EXPERIMENTAL
Intervention: Credelio Plus tablets (milbemycin oxime + lotilaner)
Number of subjects: 395

Group type: COMPARATOR
Intervention: Nexgard Spectra® tablets (control product)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Credelio Plus tablets
Number of subjects: 395
Study: 32936874

Group type: EXPERIMENTAL
Intervention: Immunonutrient supplement (3 sachets/d) enriched with l-arginine and omega-3 fatty acids
Number of subjects: 180

Group type: COMPARATOR
Intervention: Isocaloric isonitrogenous control
Number of subjects: 180
Study: 36188425

Group type: EXPERIMENTAL
Intervention: Panax notoginseng Ejiao suppository
Number of subjects: 100

Group type: COMPARATOR
Intervention: mesalazine suppository
Number of subjects: 100
Study: 33164282

Group type: EXPERIMENTAL
Intervention: Children gaining social status on a simulated social media platform
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Children losing social status on a simulated social media platform
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Parents observing their child's status gain
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Parents observing their child's status loss
Number of subjects: 123
Study: 33146324

Group type: EXPERIMENTAL
Intervention: Implementation intention strategy to promote walking
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conventional treatment in primary health care
Number of subjects: 65
Study: 35787809

Group type: EXPERIMENTAL
Intervention: Chamomile oil (1.5 cc applied to lumbar region, three times a day for three weeks)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (paraffin oil applied to lumbar region, three times a day for three weeks)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 90
Study: 33500355

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) combined with orteronel
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) combined with bicalutamide
Number of subjects: 523
Study: 35914345

Group type: EXPERIMENTAL
Intervention: Neonatal resuscitation gamification program using immersive virtual reality
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: High-fidelity neonatal resuscitation simulations and online neonatal resuscitation program lectures
Number of subjects: 83

Group type: COMPARATOR
Intervention: Online neonatal resuscitation program lectures
Number of subjects: 83
Study: 33409919

Group type: EXPERIMENTAL
Intervention: Probiotic and selenium co-supplementation (8 × 10^9 CFU/day probiotic plus 200 μg/day selenium)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Probiotic and selenium co-supplementation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 35444528

Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (MBP)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Non-preparation group
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Gut microbiota composition
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Bacteroides and Veillonella (genus)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Olsenella (genus)
Number of subjects: 81
Study: 32678530

Group type: EXPERIMENTAL
Intervention: Dexamethasone (6 mg once daily for up to 10 days)
Number of subjects: 6425

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 6425
Study: 32077229

Group type: EXPERIMENTAL
Intervention: Suction‐evacuation nephrostomy sheath (SENS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional nephrostomy sheath (NS)
Number of subjects: 60
Study: 32134283

Group type: EXPERIMENTAL
Intervention: Online personalized feedback intervention (PFI)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Personalized normative feedback (PNF)
Number of subjects: 204
Study: 32128869

Group type: EXPERIMENTAL
Intervention: Nurse home visit
Number of subjects: 651
Study: 33451891

Group type: EXPERIMENTAL
Intervention: Head lift exercises (Shaker's exercise) performed three times a day for 8 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 50
Study: 32712944

Group type: EXPERIMENTAL
Intervention: Indocyanine green angiography (ICGA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Color duplex ultrasonography (CDU)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hand-held Doppler (hhD)
Number of subjects: 12
Study: 35635335

Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid (HA)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Plasma Rich in Growth Factors (PRGF)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 3
Study: 33865349

Group type: EXPERIMENTAL
Intervention: Judo4Balance exercise programme (10 weeks)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 142
Study: 32393728

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 120
Study: 36199084

Group type: EXPERIMENTAL
Intervention: Educational intervention based on Health Belief Model (HBM) consisting of 6 virtual training sessions of 40-50 min and 2 follow-up sessions
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Educational intervention based on Health Belief Model (HBM)
Number of subjects: 150
Study: 33065768

Group type: EXPERIMENTAL
Intervention: Medical cannabis treatment
Number of subjects: 1045
Study: 36041869

Group type: EXPERIMENTAL
Intervention: Intensive SBP control (mean SBP 129.7 mmHg)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Standard SBP control (mean SBP 138.3 mmHg)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Intensive SBP control
Number of subjects: 164

Group type: COMPARATOR
Intervention: Standard SBP control
Number of subjects: 164
Study: 34022580

Group type: EXPERIMENTAL
Intervention: Greek version of the xerostomia questionnaire
Number of subjects: 72
Study: 34251903

Group type: EXPERIMENTAL
Intervention: Remdesivir (n=42)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (n=52)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Standard of Care (n=87)
Number of subjects: 181
Study: 34465368

Group type: EXPERIMENTAL
Intervention: Comprehensive Geriatric Assessment (CGA) led by a multidisciplinary team in the ED or Acute Medical Assessment Unit.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual patient care (Control group).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CGA (Intervention).
Number of subjects: 0
Study: 32967912

Group type: EXPERIMENTAL
Intervention: Sipuleucel-T (administered as three infusions)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Sipuleucel-T (first infusion)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Sipuleucel-T
Number of subjects: 2
Study: 36258655

Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Presented Centered Therapy (PCT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 37
Study: 34533246

Group type: EXPERIMENTAL
Intervention: Myrtle fruit syrup with omeprazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo syrup with omeprazole
Number of subjects: 0
Study: 35936952

Group type: EXPERIMENTAL
Intervention: King Vision video laryngoscope with COVID-19 barrier box
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope with COVID-19 barrier box
Number of subjects: 33

Group type: COMPARATOR
Intervention: King Vision video laryngoscope without COVID-19 barrier box
Number of subjects: 33

Group type: COMPARATOR
Intervention: Macintosh laryngoscope without COVID-19 barrier box
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both laryngoscopes with COVID-19 barrier box
Number of subjects: 33

Group type: COMPARATOR
Intervention: Both laryngoscopes without COVID-19 barrier box
Number of subjects: 33
Study: 35257230

Group type: EXPERIMENTAL
Intervention: Acupressure therapy (8-min acupressure from Zhongwan (CV12), Guanyuan (CV4), and Tianshu (ST25) acupoints once a day for 4 weeks)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Acupressure therapy
Number of subjects: 140
Study: 32292469

Group type: EXPERIMENTAL
Intervention: Delivery ball combined with free position midwifery nursing
Number of subjects: 110

Group type: COMPARATOR
Intervention: Conventional nursing care
Number of subjects: 110
Study: 34982724

Group type: EXPERIMENTAL
Intervention: High engagement group (completed 74% of intervention items)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Low engagement group (completed 15% of intervention items)
Number of subjects: 300
Study: 34687228

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) groups, 5 sessions of 2 hours each
Number of subjects: 85

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 85
Study: 32951538

Group type: EXPERIMENTAL
Intervention: Intensive Medical Management (IMM)
Number of subjects: 1618
Study: 34085769

Group type: EXPERIMENTAL
Intervention: YH12852 (0.05-5 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: YH12852 (0.05-0.1 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: YH12852 (doses >0.1 mg extrapolated)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gastric Emptying Breath Test (GEBT)
Number of subjects: 0
Study: 32271184

Group type: EXPERIMENTAL
Intervention: Emotional Awareness and Expression Therapy (EAET)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Education (Control)
Number of subjects: 196
Study: 33405051

Group type: COMPARATOR
Intervention: G. lucidum treatment
Number of subjects: 120